• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Roche teams up with transcription factor trailblazer Flare in new $1.8B-plus cancer pact

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 12, 2024 at 11:12: AM
via Roche and Flare Therapeutics are igniting a partnership worth more than $1.8 billion in biobucks with hopes of discovering new small molecule cancer treatments via previously undruggable transcription factor targets.

article source
 




Top Bottom
Back
Quote